<?xml version="1.0" encoding="UTF-8"?>
<!-- generated by CLiX/Wiki2XML [MPI-Inf, MMCI@UdS] $LastChangedRevision: 92 $ on 16.04.2009 15:23:09[mciao0826] -->
<!DOCTYPE article SYSTEM "../article.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
<entity  confidence="0.9511911446218017" wordnetid="100001740">
<header>
<title>Coronary artery disease</title>
<id>5876</id>
<revision>
<id>243906986</id>
<timestamp>2008-10-08T15:24:36Z</timestamp>
<contributor>
<username>Fratrep</username>
<id>4541225</id>
</contributor>
</revision>
<categories>
<category>Ischemic heart diseases</category>
<category>All NPOV disputes</category>
<category>Aging-associated diseases</category>
<category>NPOV disputes from December 2007</category>
<category>Pages with DOIs broken since 2008</category>
<category>Cardiovascular diseases</category>
</categories>
</header>
<bdy>
<template>
<name>Infobox_Disease</name>
<parameters>
<MeshID>
D003324</MeshID>
<eMedicineTopic>
192</eMedicineTopic>
<Name>
Coronary artery disease</Name>
<ICD10>
<link xlink:type="simple" xlink:href="../347/3530347.xml">
I</link><weblink xlink:type="simple" xlink:href="http://www.who.int/classifications/apps/icd/icd10online/?gi20.htm+i20">
20.</weblink>-<link xlink:type="simple" xlink:href="../347/3530347.xml">
I</link><weblink xlink:type="simple" xlink:href="http://www.who.int/classifications/apps/icd/icd10online/?gi20.htm+i25">
25.</weblink></ICD10>
<eMedicineSubj>
radio</eMedicineSubj>
<ICD9>
<weblink xlink:type="simple" xlink:href="http://www.icd9data.com/getICD9Code.ashx?icd9410">
410</weblink>-<weblink xlink:type="simple" xlink:href="http://www.icd9data.com/getICD9Code.ashx?icd9414">
414</weblink>, <weblink xlink:type="simple" xlink:href="http://www.icd9data.com/getICD9Code.ashx?icd9429.2">
429.2</weblink></ICD9>
</parameters>
</template>


<b>Coronary artery disease</b> (CAD) (or <b><link xlink:type="simple" xlink:href="../385/85385.xml">
atherosclerotic</link> <link xlink:type="simple" xlink:href="../276/69276.xml">
heart disease</link></b>) is the end result of the accumulation of <link xlink:type="simple" xlink:href="../449/838449.xml">
atheromatous plaques</link> within the walls of the <anatomy wordnetid="106057539" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../642/146642.xml">
arteries</link></anatomy>
 that supply the <link xlink:type="simple" xlink:href="../364/502364.xml">
myocardium</link> (the muscle of the <link xlink:type="simple" xlink:href="../808/36808.xml">
heart</link>) with oxygen and nutrients. It is sometimes also called <b><link xlink:type="simple" xlink:href="../735/5069735.xml">
coronary heart disease</link></b> (CHD), but although CAD is the most common cause of CHD, it is not the only cause. <p>

CAD is the leading cause of death in the U.S. While the symptoms and signs of coronary artery disease are noted in the advanced state of disease, most individuals with coronary artery disease show no evidence of disease for decades as the disease progresses before the first onset of symptoms, often a "sudden" <link xlink:type="simple" xlink:href="../969/60969.xml">
heart attack</link>, finally arise.  After decades of progression, some of these <link xlink:type="simple" xlink:href="../449/838449.xml">
atheromatous plaques</link> may rupture and (along with the activation of the <link xlink:type="simple" xlink:href="../058/183058.xml">
blood clot</link>ting system) start limiting <link xlink:type="simple" xlink:href="../499/598499.xml">
blood flow</link> to the <link xlink:type="simple" xlink:href="../348/424348.xml">
heart muscle</link>. The disease is the most common cause of <link xlink:type="simple" xlink:href="../575/60575.xml">
sudden death</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%221%22])">1</ref>, and is also the most common reason for death of men and women over 20 years of age<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%222%22])">2</ref>.
According to present trends in the United States, half of healthy 40-year-old males will develop CAD in the future, and one in three healthy 40-year-old women.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%223%22])">3</ref> According to the <link xlink:type="simple" xlink:href="../796/100796.xml">
Guinness Book of Records</link>, <country wordnetid="108544813" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../265/21265.xml">
Northern Ireland</link></country>
 is the country with the most occurrences of CAD. By contrast, the <ethnic_group wordnetid="107967382" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../523/20523.xml">
Maasai</link></ethnic_group>
 of Africa have almost no heart disease.</p>
<p>

As the degree of coronary artery disease progresses, there may be near-complete obstruction of the <link xlink:type="simple" xlink:href="../531/3432531.xml">
lumen</link> of the coronary artery, severely restricting the flow of oxygen-carrying blood to the myocardium.  Individuals with this degree of coronary artery disease typically have suffered from one or more <link xlink:type="simple" xlink:href="../969/60969.xml">
myocardial infarction</link>s (heart attacks), and may have signs and symptoms of chronic coronary ischemia, including symptoms of <link xlink:type="simple" xlink:href="../862/65862.xml">
angina</link> at rest and flash <link xlink:type="simple" xlink:href="../160/418160.xml">
pulmonary edema</link>.</p>
<p>

A distinction should be made between myocardial ischemia and myocardial infarction.  Ischemia means that the amount of oxygen supplied to the tissue is inadequate to supply the needs of the tissue.  When the myocardium becomes ischemic, it does not function optimally.  When large areas of the myocardium becomes ischemic, there can be impairment in the relaxation and contraction of the myocardium.  If the blood flow to the tissue is improved, myocardial ischemia can be reversed.  Infarction means that the tissue has undergone irreversible death due to lack of sufficient oxygen-rich blood.</p>
<p>

An individual may develop a rupture of an atheromatous plaque at <it>any</it> stage of the spectrum of coronary artery disease. The acute rupture of a plaque may lead to an acute <link xlink:type="simple" xlink:href="../969/60969.xml">
myocardial infarction</link> (heart attack).</p>

<sec>
<st>
Pathophysiology</st>
<p>

Limitation of blood flow to the heart causes <link xlink:type="simple" xlink:href="../305/490305.xml">
ischemia</link> (cell starvation secondary to a lack of oxygen) of the myocardial cells.  When myocardial cells die from lack of <link xlink:type="simple" xlink:href="../303/22303.xml">
oxygen</link>, this is called a <link xlink:type="simple" xlink:href="../969/60969.xml">
myocardial infarction</link> (commonly called a heart attack). It leads to <link xlink:type="simple" xlink:href="../348/424348.xml">
heart muscle</link> damage, <link xlink:type="simple" xlink:href="../348/424348.xml">
heart muscle</link> death and later scarring without <link xlink:type="simple" xlink:href="../348/424348.xml">
heart muscle</link> regrowth. </p>
<p>

Myocardial infarction usually results from the sudden occlusion of a coronary artery when a plaque ruptures, activating the clotting system and <link xlink:type="simple" xlink:href="../449/838449.xml">
atheroma</link>-clot interaction fills the lumen of the artery to the point of sudden closure. The <link xlink:type="simple" xlink:href="../498/682498.xml">
narrowing</link> of the lumen of the <link xlink:type="simple" xlink:href="../642/146642.xml">
heart artery</link> before sudden closure is often not severe, according to clinical research completed in the late 1990s and using <link xlink:type="simple" xlink:href="../692/852692.xml">
IVUS</link> examinations within 6 months prior to a <link xlink:type="simple" xlink:href="../969/60969.xml">
heart attack</link>. High grade <link xlink:type="simple" xlink:href="../498/682498.xml">
stenoses</link> as such exceeding 75% blockage, such as detected by <link xlink:type="simple" xlink:href="../784/733784.xml">
stress testing</link> while carrying much higher individual risk for sudden closure, were found to be responsible for only 14% of acute <link xlink:type="simple" xlink:href="../969/60969.xml">
heart attack</link>s because they are rarer compared to less severe narrowings. The events leading up to plaque rupture are not understood despite many theories. <link xlink:type="simple" xlink:href="../969/60969.xml">
Myocardial infarction</link> is almost never caused by temporary spasm of the artery wall occluding the lumen, a condition also associated with <link xlink:type="simple" xlink:href="../449/838449.xml">
atheroma</link>tous plaque and CAD.</p>
<p>

CAD is associated with <link xlink:type="simple" xlink:href="../298/73298.xml">
smoking</link>, <link xlink:type="simple" xlink:href="../677/44677.xml">
diabetes</link>, and <link xlink:type="simple" xlink:href="../432/77432.xml">
hypertension</link>.   A family history of early CAD is one of the less important predictors of CAD.  Most of the familial association of coronary artery disease are related to common dietary habits. Screening for CAD includes evaluating <link xlink:type="simple" xlink:href="../885/13885.xml">
high-density</link> and <link xlink:type="simple" xlink:href="../521/51521.xml">
low-density lipoprotein</link> (<link xlink:type="simple" xlink:href="../437/6437.xml">
cholesterol</link>) levels and <link xlink:type="simple" xlink:href="../525/56525.xml">
triglyceride</link> levels.  Despite much press, most of the alternative risk factors including homocysteine, C-reactive protein (CRP), Lipoprotein (a), coronary calcium and more sophisticated lipid analysis have added little if any additional value to the conventional risk factors of smoking, diabetes and hypertension.</p>

</sec>
<sec>
<st>
Angina</st>

<p>

<link xlink:type="simple" xlink:href="../862/65862.xml">
Angina</link> that occurs regularly with activity, after heavy meals, or at other predictable times is termed stable angina and is associated with high grade <link xlink:type="simple" xlink:href="../498/682498.xml">
narrowings</link> of the <link xlink:type="simple" xlink:href="../808/36808.xml">
heart</link> <link xlink:type="simple" xlink:href="../790/36790.xml">
arteries</link>.  The symptoms of angina are often treated with betablocker therapy such as metoprolol or atenolol.  Nitrate preparations such as <link xlink:type="simple" xlink:href="../801/3393801.xml">
nitroglycerin</link>, which come in short-acting and long-acting forms are also effective in relieving symptoms but are not known to reduce the chances of future heart attacks. Many other more effective treatments, especially of the underlying <link xlink:type="simple" xlink:href="../449/838449.xml">
atheroma</link>tous disease, have been developed.</p>
<p>

Angina that changes in intensity, character or frequency is termed unstable. Unstable angina may precede myocardial infarction, and requires urgent medical attention. It may be treated with oxygen, intravenous nitroglycerin, and aspirin. Interventional procedures such as <link xlink:type="simple" xlink:href="../279/69279.xml">
angioplasty</link> may be done.</p>

</sec>
<sec>
<st>
 Sex characteristics of coronary artery disease </st>

<ss1>
<st>
 Special Pathophysiology </st>
<p>

Typically, <link xlink:type="simple" xlink:href="../876/5876.xml">
coronary artery disease</link> occurs when part of the smooth, elastic lining inside a <link xlink:type="simple" xlink:href="../642/146642.xml">
coronary artery</link> (the arteries that supply blood to the heart muscle) develops <link xlink:type="simple" xlink:href="../385/85385.xml">
atherosclerosis</link>. With atherosclerosis, the artery's lining becomes hardened, stiffened, and swollen with all sorts of "grunge" - including calcium deposits, fatty deposits, and abnormal inflammatory <link xlink:type="simple" xlink:href="../230/4230.xml">
cells</link> - to form a <link xlink:type="simple" xlink:href="../551/167551.xml">
plaque</link>. Deposits of calcium phosphates (hydroxyapatites) in the muscular layer of the blood vessels appear to play not only a significant role in stiffening arteries but also for the induction of an early phase of coronary <link xlink:type="simple" xlink:href="../288/188288.xml">
arteriosclerosis</link>.  This can be seen in a so-called metatstatic mechanism of calcification as it occurs in chronic kidney disease and haemodialysis  (Rainer Liedtke 2008). Although these patients suffer from a kidney dysfunction, almost fifty percent of them die due to coronary artery disease. Plaques can be thought of as large "pimples" that protrude into the channel of an artery, causing a partial obstruction to blood flow. Patients with coronary artery disease might have just one or two <link xlink:type="simple" xlink:href="../551/167551.xml">
plaque</link>s, or might have dozens distributed throughout their <link xlink:type="simple" xlink:href="../642/146642.xml">
coronary arteries</link>. However, there is a term in medicine called <it>“</it>'Cardiac Syndrome X<b>”<it>, which describes chest pain (<link xlink:type="simple" xlink:href="../862/65862.xml">
Angina pectoris</link>) and chest discomfort in people who do not show signs of blockages in the larger <link xlink:type="simple" xlink:href="../642/146642.xml">
coronary arteries</link> of their hearts when an <link xlink:type="simple" xlink:href="../966/449966.xml">
angiogram</link> (coronary angiogram) is being performed<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%224%22])">4</ref>. </it></b></p>
<p>

No one knows exactly what causes “Cardiac Syndrome X” and it is unlikely to have a single cause. Today, we speculate that the major contributing factor to “Cardiac Syndrome X” is <it>“</it>'microvascular dysfunction<b>”<it>: The term “microvascular” refers to very small blood vessels and, in this case, very small <link xlink:type="simple" xlink:href="../790/36790.xml">
arteries</link> (<link xlink:type="simple" xlink:href="../444/479444.xml">
arterioles</link>, <link xlink:type="simple" xlink:href="../512/56512.xml">
capillaries</link>) of the <link xlink:type="simple" xlink:href="../808/36808.xml">
heart</link>. Studies have also shown that people with “Cardiac Syndrome X” have enhanced <link xlink:type="simple" xlink:href="../373/24373.xml">
pain</link> perception, meaning they feel chest pain more intensely than the average person. </it></b></p>
<p>

The large majority of women have the garden variety of coronary artery disease.  Rarely, women with “Cardiac Syndrome X” have typical anginal syndromes that are not associated with the presence of atherosclerotic plaques; that is, the localized blockages are absent. Scientists speculate that the blood vessels in these women are diffuse abnormal. Some have falsely claim that the entire lining of the <link xlink:type="simple" xlink:href="../790/36790.xml">
artery</link> becomes thickened throughout, making the <link xlink:type="simple" xlink:href="../551/167551.xml">
plaque</link>s flush with the wall of the <link xlink:type="simple" xlink:href="../790/36790.xml">
artery</link> without any scientific proof.  On <link xlink:type="simple" xlink:href="../713/1219713.xml">
cardiac catheterization</link> their <link xlink:type="simple" xlink:href="../642/146642.xml">
coronary arteries</link> appear smooth-walled and normal, though they may look "small" in diameter. By the way: in general, female <link xlink:type="simple" xlink:href="../642/146642.xml">
coronary arteries</link> (like all arteries) are somewhat smaller than in males.<image width="150px" src="Coro_Man.jpg" type="thumb">
<caption>

Coronary angiogram of a man
</caption>
</image>
<image width="150px" src="Coro_Woman.jpg" type="thumb">
<caption>

Coronary angiogram of a woman
</caption>
</image>
</p>
<p>

“Cardiac Syndrome X” have never been shown to cause acute heart attacks (<link xlink:type="simple" xlink:href="../969/60969.xml">
myocardial infarction</link>) despite much speculation. The prognosis with syndrome-X coronary artery disease is also known to be better than with typical <link xlink:type="simple" xlink:href="../876/5876.xml">
coronary artery disease</link>, but this is not a benign condition since it can be quite disabling. 
It is not completely clear why women are more likely than men to suffer from "Syndrome X"; however, <link xlink:type="simple" xlink:href="../311/13311.xml">
hormone</link>s and other risk factors unique to women may play a role<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%225%22])">5</ref>. Women’s blood vessels are exposed to changing levels of <link xlink:type="simple" xlink:href="../581/22581.xml">
oestrogen</link> throughout their lives, first during regular menstrual cycles and later during and after <link xlink:type="simple" xlink:href="../611/49611.xml">
menopause</link> as <link xlink:type="simple" xlink:href="../581/22581.xml">
oestrogen</link> levels decline with age. <link xlink:type="simple" xlink:href="../581/22581.xml">
Oestrogen</link> affects how blood vessels narrow and widen and how they respond to injury, so changes in <link xlink:type="simple" xlink:href="../581/22581.xml">
oestrogen</link> levels mean changes in the reactivity of the blood vessels. Women’s vessels may be “programmed” for more changes than men’s vessels, which could increase the risk of having problems in the lining of the <link xlink:type="simple" xlink:href="../790/36790.xml">
arteries</link> (<link xlink:type="simple" xlink:href="../570/532570.xml">
endothelial cells</link>) and the <link xlink:type="simple" xlink:href="../381/300381.xml">
smooth muscle</link> cells in the walls of the arteries. 
The endothelial dysfunction is likely to be multifactorial in these patients and it is conceivable that risk factors such as <link xlink:type="simple" xlink:href="../432/77432.xml">
hypertension</link>, <link xlink:type="simple" xlink:href="../039/513039.xml">
hypercholesterolemia</link>, <link xlink:type="simple" xlink:href="../677/44677.xml">
diabetes mellitus</link> and smoking can contribute to its development. Most patients with Syndrome X are postmenopausal women and <link xlink:type="simple" xlink:href="../581/22581.xml">
oestrogen</link> deficiency has been therefore proposed as a pathogenic factor in female patients. In addition to changing hormone levels, there are several other risk conditions for blood vessel problems that are unique to women, such as <link xlink:type="simple" xlink:href="../967/414967.xml">
preeclampsia</link> (a problem associated with high blood pressure during pregnancy) and delivering a low-birth weight baby.  Of course, despite these issues women, the female gender as a whole is protective against coronary artery disease.</p>

</ss1>
<ss1>
<st>
 Symptoms </st>
<p>

Cardiac Syndrome X often is a diagnosis of exclusion where the presence of <b>typical</b> chest pains is not accompanied by coronary artery narrowings on angiography. In considering Syndrome-X, it is important to understand that about 80% of chest pains have nothing to do with the heart.  Therefore, the characteristics of typical chest pains must be carefully documented to avoid unnecessary labelling patients with heart disease:</p>
<p>

<list>
<entry level="1" type="bullet">

 Chest pain or <link xlink:type="simple" xlink:href="../972/8144972.xml">
Angina</link> with physical stress; the <link xlink:type="simple" xlink:href="../373/24373.xml">
pain</link> may spread to the left arm or the neck, back, throat, or jaw. There might be present a numbness (<link xlink:type="simple" xlink:href="../940/398940.xml">
paresthesia</link>) or a loss of feeling in the arms, shoulders, or wrists. </entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../832/582832.xml">
Coronary angiography</link> demonstrates “normal” coronary arteries, i. e. no blockages or stenoses can be detected in the larger <link xlink:type="simple" xlink:href="../255/4978255.xml">
epicardial</link> vessels.</entry>
<entry level="1" type="bullet">

 No inducible coronary artery <link xlink:type="simple" xlink:href="../177/173177.xml">
spasm</link> present during <link xlink:type="simple" xlink:href="../713/1219713.xml">
cardiac catheterization</link>.</entry>
<entry level="1" type="bullet">

 Characteristic <link xlink:type="simple" xlink:href="../305/490305.xml">
ischemic</link> <link xlink:type="simple" xlink:href="../988/76988.xml">
ECG</link> changes during exercise testing.</entry>
<entry level="1" type="bullet">

 <link>
ST segment</link> depression and angina in the presence of left ventricular wall perfusion abnormalities during thallium or other stress perfusion test.</entry>
<entry level="1" type="bullet">

 Consistent response to sublingual <link xlink:type="simple" xlink:href="../497/21497.xml">
nitrate</link>s. </entry>
<entry level="1" type="bullet">

 Postmenopausal or <link xlink:type="simple" xlink:href="../611/49611.xml">
menopausal</link> status.</entry>
</list>
</p>
<p>

The diagnosis of “Cardiac Syndrome X” - the rare coronary artery disease that is more common in women, as mentioned, an “exclusion” diagnosis. Therefore, usually the same tests are used as in any patient with the suspicion of coronary artery disease:
<list>
<entry level="1" type="bullet">

 Baseline ECG</entry>
<entry level="1" type="bullet">

 Exercise ECG – Stress test</entry>
<entry level="1" type="bullet">

 Exercise radioisotope test (nuclear stress test, myocardial <link xlink:type="simple" xlink:href="../838/347838.xml">
scintigraphy</link>).</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../617/337617.xml">
Echocardiography</link> (including stress echocardiography).</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../832/582832.xml">
Coronary angiography</link>.</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../692/852692.xml">
Intravascular ultrasound</link>.</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../450/19450.xml">
MRI</link> scan.</entry>
</list>
</p>

</ss1>
<ss1>
<st>
Therapy</st>
<p>

A variety of drugs are used in the attempt to treat the Syndrome-X coronary artery disease: <link xlink:type="simple" xlink:href="../497/21497.xml">
nitrate</link>s, <link xlink:type="simple" xlink:href="../559/252559.xml">
calcium channel antagonist</link>s, <link xlink:type="simple" xlink:href="../767/2767.xml">
ACE-inhibitor</link>s, <link xlink:type="simple" xlink:href="../197/178197.xml">
statin</link>s, imipramin (<link xlink:type="simple" xlink:href="../ury/23rd_century.xml">
analgesia</link>), <link xlink:type="simple" xlink:href="../818/2294818.xml">
aminophylline</link>, hormone replacement therapy (<link xlink:type="simple" xlink:href="../581/22581.xml">
oestrogen</link>), even electrical <link xlink:type="simple" xlink:href="../230/4793230.xml">
spinal cord stimulation</link> are tried to overcome the symptomatology -all with mixed results. Quite often the quality of life for these women remains poor.
While not enough is known about Syndrome-X coronary artery disease to list specific <link xlink:type="simple" xlink:href="../878/1228878.xml">
prevention</link> techniques, adopting heart-healthy habits can be a good start. These include monitoring <link xlink:type="simple" xlink:href="../437/6437.xml">
cholesterol</link> and <link xlink:type="simple" xlink:href="../558/56558.xml">
blood pressure</link> levels, maintaining a low-fat <link xlink:type="simple" xlink:href="../461/8461.xml">
diet</link>, exercising regularly, quitting smoking, avoiding recreational drugs, and moderating alcohol intake. However, there might be a new option for women suffering from “Cardiac Syndrome X”: Protein based <link xlink:type="simple" xlink:href="../972/64972.xml">
Angiogenesis</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%226%22])">6</ref>. This new <link xlink:type="simple" xlink:href="../634/23634.xml">
protein</link>-based angiogenic therapy - using <link xlink:type="simple" xlink:href="../960/4143960.xml">
fibroblast growth factor</link> 1 (FGF-1) - might be used as sole therapy as well as adjunct to <link xlink:type="simple" xlink:href="../737/1308737.xml">
bypass surgery</link> – thus overcoming the limitations of conventional bypass surgery.<image width="150px" src="Coro_Woman_FGF-1.jpg" type="thumb">
<caption>

Neo-angiogenesis in a woman's heart after FGF-1 treatment
</caption>
</image>
 Beyond drug therapy, interventional procedures, and coronary artery bypass grafting, <link xlink:type="simple" xlink:href="../972/64972.xml">
angiogenesis</link> now offers a new, specific and – so far as we know from three human clinical trials – effective treatment targeted for women’s coronary artery disease<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%227%22])">7</ref>.</p>

</ss1>
</sec>
<sec>
<st>
 Risk factors </st>
<p>

<b>The following are confirmed <link>
independent risk factors</link> for the development of CAD:</b>
<list>
<entry level="1" type="number">

 <link xlink:type="simple" xlink:href="../039/513039.xml">
Hypercholesterolemia</link> (specifically, serum <link xlink:type="simple" xlink:href="../521/51521.xml">
LDL</link> concentrations)</entry>
<entry level="1" type="number">

 <link xlink:type="simple" xlink:href="../298/73298.xml">
Smoking</link></entry>
<entry level="1" type="number">

 <link xlink:type="simple" xlink:href="../432/77432.xml">
Hypertension</link> (high systolic pressure seems to be most significant in this regard)</entry>
<entry level="1" type="number">

 <link xlink:type="simple" xlink:href="../226/78226.xml">
Hyperglycemia</link> (due to diabetes mellitus or otherwise)</entry>
<entry level="1" type="number">

 <link xlink:type="simple" xlink:href="../268/1699268.xml">
Type A Behavioural Patterns, TABP</link>. Added in 1981 as an independent risk factor after a majority of research into the field discovered that TABP's were twice as likely to exhibit CAD than any other personality type.</entry>
<entry level="1" type="number">

 Hemostatic Factors<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%228%22])">8</ref>: High levels of fibrinogen and coagulation factor VII are associated with an increased risk of CAD. Factor VII levels are higher in individuals with a high intake of dietary fat. Decreased fibrinolytic activity has been reported in patients with coronary atherosclerosis.</entry>
<entry level="1" type="number">

 Hereditary differences in such diverse aspects as lipoprotein structure and that of their associated receptors, homocysteine processing/metabolism, etc.</entry>
</list>
</p>
<p>

<b>Significant, but indirect risk factors include:</b>
<list>
<entry level="1" type="bullet">

 Lack of <link xlink:type="simple" xlink:href="../037/189037.xml">
exercise</link></entry>
<entry level="1" type="bullet">

 Stress</entry>
<entry level="1" type="bullet">

 Diet rich in <link xlink:type="simple" xlink:href="../746/264746.xml">
saturated fat</link>s</entry>
<entry level="1" type="bullet">

 Diet low in <link xlink:type="simple" xlink:href="../277/3277.xml">
antioxidant</link>s</entry>
<entry level="1" type="bullet">

 <link xlink:type="simple" xlink:href="../435/56435.xml">
Obesity</link></entry>
<entry level="1" type="bullet">

 Men over 60; Women over 65<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%229%22])">9</ref></entry>
</list>
</p>
<p>

<b>Risk factors can be classified as</b>
<list>
<entry level="1" type="number">

Fixed: age, sex, family history</entry>
<entry level="1" type="number">

Modifiable: smoking, hypertension, diabetes mellitus, obesity, etc.</entry>
</list>
</p>

</sec>
<sec>
<st>
 Prevention </st>
<p>

Coronary artery disease is the most common form of heart disease in the Western world. Prevention centers on the modifiable risk factors, which include decreasing <link xlink:type="simple" xlink:href="../437/6437.xml">
cholesterol</link> levels, addressing <link xlink:type="simple" xlink:href="../435/56435.xml">
obesity</link> and <link xlink:type="simple" xlink:href="../432/77432.xml">
hypertension</link>, avoiding a <link xlink:type="simple" xlink:href="../480/1676480.xml">
sedentary lifestyle</link>, making healthy dietary choices, and <link xlink:type="simple" xlink:href="../607/289607.xml">
stopping smoking</link>. There is some evidence that lowering <link xlink:type="simple" xlink:href="../223/105223.xml">
homocysteine</link> levels may contribute to more heart attacks (NORVIT trial). In <link xlink:type="simple" xlink:href="../677/44677.xml">
diabetes mellitus</link>, there is little evidence that very tight <link xlink:type="simple" xlink:href="../406/289406.xml">
blood sugar</link> control actually improves cardiac risk although improved sugar control appears to decrease other undesirable problems like kidney failure and blindness. Some recommend a diet rich in omega-3 fatty acids and <link xlink:type="simple" xlink:href="../509/32509.xml">
vitamin C</link>. The <organization wordnetid="108008335" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../583/33583.xml">
World Health Organization</link></organization>
 (WHO) recommends "low to moderate alcohol intake" to reduce risk of coronary artery disease although this remains without scientific cause and effect proof.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2210%22])">10</ref></p>
<p>

An increasingly growing number of other <link xlink:type="simple" xlink:href="../597/23597.xml">
physiological</link> markers and <link xlink:type="simple" xlink:href="../980/13980.xml">
homeostatic</link> mechanisms are currently under scientific investigation.  Patients with CAD and those trying to prevent CAD are advised to avoid fats that are readily oxidized (e.g., saturated fats and <link xlink:type="simple" xlink:href="../487/263487.xml">
trans-fats</link>), limit carbohydrates and processed sugars to reduce production of <link xlink:type="simple" xlink:href="../521/51521.xml">
Low density lipoprotein</link>s, <link xlink:type="simple" xlink:href="../525/56525.xml">
triacylglycerol</link> and apolipoprotein-B.
<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2211%22])">11</ref>
<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2212%22])">12</ref>
<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2213%22])">13</ref>
<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2214%22])">14</ref>
<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2215%22])">15</ref>
It is also important to keep <link xlink:type="simple" xlink:href="../558/56558.xml">
blood pressure</link> normal, exercise and stop smoking.  These measures reduces the development of heart attacks.  Recent studies have shown that dramatic reduction in LDL levels can cause regression of coronary artery disease in as many as 2/3 of patients after just one year of sustained treatment.</p>
<p>

Menaquinone (<link xlink:type="simple" xlink:href="../541/32541.xml">
Vitamin K2</link>), but not phylloquinone (<link xlink:type="simple" xlink:href="../541/32541.xml">
Vitamin K1</link>), intake is associated with reduced risk of CAD <link xlink:type="simple" xlink:href="../221/8221.xml">
mortality</link>, all-cause mortality and severe aortic calcification.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2216%22])">16</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2217%22])">17</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2218%22])">18</ref>  </p>

</sec>
<sec>
<st>
Exercise</st>
<p>

Separate to the question of the benefits of exercise; it is unclear whether doctors should spend time counseling patients to exercise. The <weblink xlink:type="simple" xlink:href="http://www.ahrq.gov/clinic/uspstfix.htm">
U.S. Preventive Services Task Force (USPSTF)</weblink>, based on a <link xlink:type="simple" xlink:href="../579/2994579.xml">
systematic review</link> of <link xlink:type="simple" xlink:href="../180/163180.xml">
randomized controlled trials</link>, found 'insufficient evidence' to recommend that doctors counsel patients on exercise, but "it did not review the evidence for the effectiveness of physical activity to reduce chronic disease, morbidity and mortality", it only examined the effectiveness of the counseling itself.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2219%22])">19</ref> However, the <link xlink:type="simple" xlink:href="../673/581673.xml">
American Heart Association</link>, based on a non-systematic review, recommends that doctors counsel patients on exercise <ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2220%22])">20</ref></p>

</sec>
<sec>
<st>
Preventive diets</st>

<p>

<table class="metadata plainlinks ambox ">
<row>
<col>

ambox-content" style=""</col>
</row>
<row>
<col class="mbox-image"><p>

<image width="40px" src="Unbalanced_scales.svg">
</image>
</p>
</col>
<col style="" class="mbox-text">
 <b>The  of this section is .</b> 
Please see the discussion on the . <it>(December 2007)</it>Please do not remove this message until the </col>
</row>
</table>

</p>
<p>

<indent level="1">

<it>Main article: <link xlink:type="simple" xlink:href="../846/4354846.xml">
Diet and Heart Disease</link></it>
</indent>
It has been suggested that coronary artery disease is partially reversible using an intense dietary regimen coupled with regular cardio exercise.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2221%22])">21</ref></p>
<p>

<list>
<entry level="1" type="bullet">

Vegetarian diet: <link xlink:type="simple" xlink:href="../591/32591.xml">
Vegetarians</link> have been shown to have a 24% reduced risk of dying of heart disease.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2222%22])">22</ref></entry>
</list>
</p>
<p>

<list>
<entry level="1" type="bullet">

Cretan <link xlink:type="simple" xlink:href="../499/460499.xml">
Mediterranean diet</link>: The Seven Country Study found that <link xlink:type="simple" xlink:href="../591/6591.xml">
Cretan</link> men had exceptionally low death rates from heart disease, despite moderate to high intake of fat. The Cretan diet is similar to other traditional Mediterranean diets: consisting mostly of <link xlink:type="simple" xlink:href="../478/22478.xml">
olive oil</link>, bread, abundant fruit and vegetables, a moderate amount of wine and fat-rich animal products such as lamb, sausage and <link xlink:type="simple" xlink:href="../368/444368.xml">
goat cheese</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2223%22])">23</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2224%22])">24</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2225%22])">25</ref>  However, the Cretan diet consisted of less fish and wine consumption than some other Mediterranean-style diets, such as the diet in <body wordnetid="107965085" confidence="0.8">
<social_group wordnetid="107950920" confidence="0.8">
<colony wordnetid="108374049" confidence="0.8">
<group wordnetid="100031264" confidence="0.8">
<link xlink:type="simple" xlink:href="../462/45462.xml">
Corfu</link></group>
</colony>
</social_group>
</body>
, another region of Greece, which had higher death rates.</entry>
</list>
</p>
<p>

The consumption of <link xlink:type="simple" xlink:href="../487/263487.xml">
trans fat</link> (commonly found in <link xlink:type="simple" xlink:href="../968/235968.xml">
hydrogenated</link> products such as <link xlink:type="simple" xlink:href="../276/193276.xml">
margarine</link>) has been shown to cause the development of <link xlink:type="simple" xlink:href="../612/916612.xml">
endothelial dysfunction</link>, a precursor to <link xlink:type="simple" xlink:href="../385/85385.xml">
atherosclerosis</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2226%22])">26</ref>The consumption of trans fatty acids has been shown to increase the risk of coronary artery disease<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2227%22])">27</ref></p>
<p>

Foods containing <link xlink:type="simple" xlink:href="../558/140558.xml">
fiber</link>, <link xlink:type="simple" xlink:href="../055/23055.xml">
potassium</link>, <link xlink:type="simple" xlink:href="../287/235287.xml">
nitric oxide</link> (in green leafy vegetables), <link xlink:type="simple" xlink:href="../404/1051404.xml">
monounsaturated fat</link>, <link xlink:type="simple" xlink:href="../513/1610513.xml">
polyunsaturated fat</link>, <link xlink:type="simple" xlink:href="../668/591668.xml">
saponin</link>s, or <link xlink:type="simple" xlink:href="../023/525023.xml">
lecithin</link> are said to lower cholesterol levels. Foods high in <link xlink:type="simple" xlink:href="../610/43610.xml">
grease</link>, <link xlink:type="simple" xlink:href="../200/1605200.xml">
salt</link>, <link xlink:type="simple" xlink:href="../487/263487.xml">
trans fat</link>, or <link xlink:type="simple" xlink:href="../746/264746.xml">
saturated fat</link> are said to raise cholesterol levels.</p>

</sec>
<sec>
<st>
 Aspirin </st>
<p>

Aspirin, in doses of less than 75 to 81 mg/d<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2228%22])">28</ref>, can reduce the incidence of cardiovascular events.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2229%22])">29</ref> The <weblink xlink:type="simple" xlink:href="http://www.ahrq.gov/clinic/uspstfix.htm">
U.S. Preventive Services Task Force</weblink> 'strongly recommends that clinicians discuss aspirin chemoprevention with adults who are at increased risk for coronary artery disease'.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2230%22])">30</ref> The Task Force defines increased risk as 'Men older than 40 years of age, postmenopausal women, and younger persons with risk factors for coronary artery disease (for example, hypertension, diabetes, or smoking) are at increased risk for heart disease and may wish to consider aspirin therapy'. More specifically, high-risk persons are 'those with a 5-year risk ≥ 3%'. A risk calculator is available.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2231%22])">31</ref></p>
<p>

Regarding healthy women, the more recent <link>
Women's Health Study</link> <link xlink:type="simple" xlink:href="../180/163180.xml">
randomized controlled trial</link> found <link xlink:type="simple" xlink:href="../995/160995.xml">
insignficant</link> benefit from aspirin in the reduction of cardiac events; however there was a <link xlink:type="simple" xlink:href="../995/160995.xml">
signficant</link> reduction in <link xlink:type="simple" xlink:href="../404/625404.xml">
stroke</link>.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2232%22])">32</ref> <link xlink:type="simple" xlink:href="../504/5434504.xml">
Subgroup analysis</link> showed that all benefit was confined to women over 65 years old.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2232%22])">32</ref> In spite of the <link xlink:type="simple" xlink:href="../995/160995.xml">
insignficant</link> benefit for women  65 years old, recent <link xlink:type="simple" xlink:href="../685/1294685.xml">
practice guidelines</link> by the <link xlink:type="simple" xlink:href="../673/581673.xml">
American Heart Association</link> recommend to 'consider' aspirin in 'healthy women' 65 years of age 'when benefit for ischemic stroke prevention is likely to outweigh adverse effects of therapy'.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2233%22])">33</ref></p>

</sec>
<sec>
<st>
 Omega-3 fatty acids </st>
<p>

The benefit of fish oil is controversial with conflicting conclusions reached by a negative <link xlink:type="simple" xlink:href="../329/62329.xml">
meta-analysis</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2234%22])">34</ref> of <link xlink:type="simple" xlink:href="../180/163180.xml">
randomized controlled trials</link> by the international <link xlink:type="simple" xlink:href="../721/237721.xml">
Cochrane Collaboration</link> and a partially positive <link xlink:type="simple" xlink:href="../579/2994579.xml">
systematic review</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2235%22])">35</ref> by the <link xlink:type="simple" xlink:href="../517/1704517.xml">
Agency for Healthcare Research and Quality</link>. Since these two reviews, a <link xlink:type="simple" xlink:href="../180/163180.xml">
randomized controlled trial</link> reported a reduction on coronary events in Japanese hypercholesterolemic patients.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2236%22])">36</ref></p>
<p>

<link xlink:type="simple" xlink:href="../594/22594.xml">
Omega-3</link> fatty acids are also found in some plant sources including <link xlink:type="simple" xlink:href="../711/295711.xml">
flax seed oil</link>, <link xlink:type="simple" xlink:href="../632/324632.xml">
hemp seed oil</link>, and <link xlink:type="simple" xlink:href="../140/165140.xml">
walnut</link>s.  Plant sources may be safer as fish products have been shown to contain heavy metals and other fat soluble  pollutants.</p>

</sec>
<sec>
<st>
 Secondary prevention </st>
<p>

Secondary prevention is preventing further sequelae of already established disease. Regarding coronary artery disease, this can mean risk factor management that is carried out during cardiac rehabilitation, a 4-phase process beginning in hospital after MI, angioplasty or heart surgery and continuing for a minimum of three months. Exercise is a main component of cardiac rehabilitation along with diet, smoking cessation, and blood pressure and cholesterol management. Beta blockers may also be used for this purpose.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2237%22])">37</ref></p>

<ss2>
<st>
Anti-platelet therapy</st>
<p>

A <link xlink:type="simple" xlink:href="../329/62329.xml">
meta-analysis</link> of <link xlink:type="simple" xlink:href="../180/163180.xml">
randomized controlled trials</link> by the international <link xlink:type="simple" xlink:href="../721/237721.xml">
Cochrane Collaboration</link> found "that the use of clopidogrel plus aspirin is associated with a reduction in the risk of cardiovascular events compared with aspirin alone in patients with acute non-ST coronary syndrome. In patients at high risk of cardiovascular disease but not presenting acutely, there is only weak evidence of benefit and hazards of treatment almost match any benefit obtained.".<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2238%22])">38</ref></p>

</ss2>
</sec>
<sec>
<st>
 Therapy - Principles of Treatment </st>
<p>

Therapeutic options for coronary artery disease<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2239%22])">39</ref> today are based on three principles: 
<list>
<entry level="1" type="bullet">

1. Medical treatment - drugs (e.g. cholesterol lowering medications, beta-blockers, nitroglycerin, calcium antagonists, etc.); </entry>
<entry level="1" type="bullet">

2. Coronary interventions as <link xlink:type="simple" xlink:href="../279/69279.xml">
angioplasty</link> and <link xlink:type="simple" xlink:href="../245/13892245.xml">
coronary stent</link>-implantation; </entry>
<entry level="1" type="bullet">

3. Coronary artery bypass grafting (CABG - <link xlink:type="simple" xlink:href="../248/195248.xml">
coronary artery bypass surgery</link>). </entry>
</list>

Recent research efforts focus on new angiogenic treatment modalities (<link xlink:type="simple" xlink:href="../972/64972.xml">
angiogenesis</link>) and various (adult) <link xlink:type="simple" xlink:href="../783/27783.xml">
stem cell</link> therapies.</p>

</sec>
<sec>
<st>
 Recent research </st>

<p>

<indent level="1">

<it>Further information: <link xlink:type="simple" xlink:href="../449/838449.xml">
atheroma</link> and <link xlink:type="simple" xlink:href="../385/85385.xml">
atherosclerosis</link></it>
</indent>
A 2006 study by the <hospital wordnetid="103540595" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../958/1278958.xml">
Cleveland Clinic</link></hospital>
 found a region on Chromosome 17 was confined to families with multiple cases of myocardial infarction.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2240%22])">40</ref></p>
<p>

A more controversial link is that between <it><link xlink:type="simple" xlink:href="../062/1709062.xml">
Chlamydophila pneumoniae</link></it> infection and atherosclerosis.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2241%22])">41</ref> While this intracellular organism has been demonstrated in atherosclerotic plaques, evidence is inconclusive as to whether it can be considered a causative factor. Treatment with antibiotics in patients with proven atherosclerosis has not demonstrated a decreased risk of heart attacks or other coronary vascular diseases.<ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2242%22])">42</ref></p>
<p>

Since the 1990s the search for new treatment options for coronary artery disease patients, particularly for so called "no-option" coronary patients, focused on usage of <link xlink:type="simple" xlink:href="../972/64972.xml">
angiogenesis</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2243%22])">43</ref> and (adult) <link xlink:type="simple" xlink:href="../783/27783.xml">
stem cell</link> therapies. Numerous clinical trials were performed, either applying <link xlink:type="simple" xlink:href="../634/23634.xml">
protein</link> (angiogenic <link xlink:type="simple" xlink:href="../041/13041.xml">
growth factor</link>) therapies, such as <link xlink:type="simple" xlink:href="../993/4143993.xml">
FGF-1</link> or <link xlink:type="simple" xlink:href="../534/1858534.xml">
VEGF</link>, or cell therapies using different kinds of adult <link xlink:type="simple" xlink:href="../783/27783.xml">
stem cell</link> populations. Research is still going on - with first promising results particularly for <link xlink:type="simple" xlink:href="../993/4143993.xml">
FGF-1</link><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2244%22])">44</ref><ref xlink:type="simple" xlink:href="#xpointer(//reflist/entry[@id=%2245%22])">45</ref> and utilization of endothelial <link xlink:type="simple" xlink:href="../586/5523586.xml">
progenitor cells</link>.</p>

</sec>
<sec>
<st>
References</st>

<p>

<reflist>
<entry id="1">
 <cite style="font-style:normal">Thomas AC, Knapman PA, Krikler DM, Davies MJ&#32;(December 1988).&#32;"<weblink xlink:type="simple" xlink:href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1835183">
Community study of the causes of "natural" sudden death</weblink>". <it>BMJ</it>&#32;<b>297</b>&#32;(6661): 1453–6. PMID 3147014. <link xlink:type="simple" xlink:href="../325/2775325.xml">
PMC</link>:<weblink xlink:type="simple" xlink:href="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1835183">
1835183</weblink>.</cite>&nbsp;</entry>
<entry id="2">
American Heart Association: <weblink xlink:type="simple" xlink:href="http://www.americanheart.org/presenter.jhtml?identifier=3000090">
Heart Disease and Stroke Statistics</weblink>-2007 Update. AHA, Dallas, Texas, 2007</entry>
<entry id="3">
 <cite style="font-style:normal">Rosamond W, Flegal K, Friday G, et al&#32;(February 2007).&#32;"<weblink xlink:type="simple" xlink:href="http://circ.ahajournals.org/cgi/content/full/115/5/e69/TBL3179728">
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee</weblink>". <it>Circulation</it>&#32;<b>115</b>&#32;(5): e69–171. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1161%2FCIRCULATIONAHA.106.179918">
10.1161/CIRCULATIONAHA.106.179918</weblink>. PMID 17194875.</cite>&nbsp;</entry>
<entry id="4">
 <cite style="font-style:normal">Lanza GA&#32;(February 2007).&#32;"Cardiac syndrome X: a critical overview and future perspectives". <it>Heart</it>&#32;<b>93</b>&#32;(2): 159–66. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1136%2Fhrt.2005.067330">
10.1136/hrt.2005.067330</weblink>. PMID 16399854.</cite>&nbsp;</entry>
<entry id="5">
 <cite style="font-style:normal">Kaski JC&#32;(February 2004).&#32;"Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X)". <it>Circulation</it>&#32;<b>109</b>&#32;(5): 568–72. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1161%2F01.CIR.0000116601.58103.62">
10.1161/01.CIR.0000116601.58103.62</weblink>. PMID 14769677.</cite>&nbsp;</entry>
<entry id="6">
Stegmann, T.J.: New Vessels for the Heart. Angiogenesis as New Treatment for Coronary Heart Disease: The Story of its Discovery and Development. Henderson, Nevada 89012, USA, 2004. ISBN 0-976558-30-5 </entry>
<entry id="7">
Stegmann, T.J.: Protein promise in heart disease. GCPj, March 2007, 21-24</entry>
<entry id="8">
http://atvb.ahajournals.org/cgi/content/full/atvbaha;17/11/3321</entry>
<entry id="9">
<weblink xlink:type="simple" xlink:href="http://findarticles.com/p/articles/mi_m0857/is_n6_v13/ai_17942856">
Women and heart disease | Health News | Find Articles at BNET</weblink></entry>
<entry id="10">
"<weblink xlink:type="simple" xlink:href="http://www.who.int/nutrition/topics/5_population_nutrient/en/index12.html">
5. Population nutrient intake goals for preventing diet-related chronic diseases</weblink>".&#32;  WHO.</entry>
<entry id="11">
 <cite style="font-style:normal">Swarbrick MM, Stanhope KL, Elliott SS, et al&#32;(April 2008).&#32;"Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women". <it>Br. J. Nutr.</it>: 1–6. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1017%2FS0007114508968252">
10.1017/S0007114508968252</weblink>. PMID 18384705.</cite>&nbsp;</entry>
<entry id="12">
 <cite style="font-style:normal">Culling KS, Neil HA, Gilbert M, Frayn KN&#32;(December 2007).&#32;"Effects of short-term low- and high-carbohydrate diets on postprandial metabolism in non-diabetic and diabetic subjects". <it>Nutr Metab Cardiovasc Dis</it>. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.numecd.2007.09.003">
10.1016/j.numecd.2007.09.003</weblink>. PMID 18083355.</cite>&nbsp;</entry>
<entry id="13">
 <cite style="font-style:normal">Parks EJ, Skokan LE, Timlin MT, Dingfelder CS&#32;(June 2008).&#32;"<weblink xlink:type="simple" xlink:href="http://jn.nutrition.org/cgi/pmidlookup?view=long&amp;pmid=18492831">
Dietary sugars stimulate fatty acid synthesis in adults</weblink>". <it>J. Nutr.</it>&#32;<b>138</b>&#32;(6): 1039–46. PMID 18492831.</cite>&nbsp;</entry>
<entry id="14">
 <cite style="font-style:normal">Lofgren IE, Herron KL, West KL, et al&#32;(April 2005).&#32;"Carbohydrate intake is correlated with biomarkers for coronary heart disease in a population of overweight premenopausal women". <it>J. Nutr. Biochem.</it>&#32;<b>16</b>&#32;(4): 245–50. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.jnutbio.2004.12.008">
10.1016/j.jnutbio.2004.12.008</weblink>. PMID 15808329.</cite>&nbsp;</entry>
<entry id="15">
 <cite style="font-style:normal">Aeberli I, Zimmermann MB, Molinari L, et al&#32;(October 2007).&#32;"<weblink xlink:type="simple" xlink:href="http://www.ajcn.org/cgi/pmidlookup?view=long&amp;pmid=17921399">
Fructose intake is a predictor of LDL particle size in overweight schoolchildren</weblink>". <it>Am. J. Clin. Nutr.</it>&#32;<b>86</b>&#32;(4): 1174–8. PMID 17921399.</cite>&nbsp;</entry>
<entry id="17">
 <cite style="font-style:normal">Erkkilä AT, Booth SL&#32;(2008).&#32;"Vitamin K intake and atherosclerosis". <it>Curr. Opin. Lipidol.</it>&#32;<b>19</b>&#32;(1): 39–42. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:10.1097/MOL.0b013e3282f1c57f (inactive <link>
2008-06-24</link>) . PMID 18196985.</cite>&nbsp;</entry>
<entry id="16">
 <cite style="font-style:normal">Geleijnse JM, Vermeer C, Grobbee DE, et al&#32;(2004).&#32;"Dietary intake of menaquinone is associated with a reduced risk of coronary artery disease: the Rotterdam Study". <it>J. Nutr.</it>&#32;<b>134</b>&#32;(11): 3100–5. PMID 15514282.</cite>&nbsp;</entry>
<entry id="19">
 <cite style="font-style:normal">&#32;"Behavioral counseling in primary care to promote physical activity: recommendation and rationale"&#32;&#32;(2002). <it>Ann. Intern. Med.</it>&#32;<b>137</b>&#32;(3): 205–7. PMID 12160370.</cite>&nbsp;</entry>
<entry id="18">
 <cite style="font-style:normal">Wallin R, Schurgers L, Wajih N&#32;(2008).&#32;"Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification". <it>Thromb. Res.</it>. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2Fj.thromres.2007.12.005">
10.1016/j.thromres.2007.12.005</weblink>. PMID 18234293.</cite>&nbsp;</entry>
<entry id="21">
 <cite style="font-style:normal">Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL.&#32;(1990).&#32;"Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial". <it>Lancet</it>&#32;<b>336</b>&#32;(8708): 129–33. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2F0140-6736%2890%2991656-U">
10.1016/0140-6736(90)91656-U</weblink>. PMID 1973470.</cite>&nbsp;</entry>
<entry id="20">
 <cite style="font-style:normal">Thompson PD, Buchner D, Pina IL, et al&#32;(2003).&#32;"Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity)". <it>Circulation</it>&#32;<b>107</b>&#32;(24): 3109–16. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1161%2F01.CIR.0000075572.40158.77">
10.1161/01.CIR.0000075572.40158.77</weblink>. PMID 12821592.</cite>&nbsp; http://www.ngc.gov/summary/summary.aspx?ss=15&amp;doc_id=5360&amp;string=#s23</entry>
<entry id="23">
 <cite style="font-style:normal">Willett WC, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, Trichopoulos D.&#32;(1995).&#32;"Mediterranean diet pyramid: a cultural model for healthy eating". <it>Am J Clin Nutr</it>&#32;<b>61</b>&#32;(6 Suppl): 1402S–1406S. PMID 7754995.</cite>&nbsp;</entry>
<entry id="22">
 <cite style="font-style:normal">Key TJ, Fraser GE, Thorogood M, Appleby PN, Beral V, Reeves G, Burr ML, Chang-Claude J, Frentzel-Beyme R, Kuzma JW, Mann J, McPherson K&#32;(1998).&#32;"Mortality in vegetarians and non-vegetarians: a collaborative analysis of 8300 deaths among 76,000 men and women in five prospective studies". <it>Public Health Nutr</it>&#32;<b>1</b>&#32;(1): 33–41. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1079%2FPHN19980006">
10.1079/PHN19980006</weblink>. PMID 10555529.</cite>&nbsp;</entry>
<entry id="25">
 <cite style="font-style:normal">Alberti-Fidanza A, Paolacci CA, Chiuchiu MP, Coli R, Fruttini D, Verducci G, Fidanza F.&#32;(1994).&#32;"Dietary studies on two rural Italian population groups of the Seven Countries Study. 1. Food and nutrient intake at the thirty-first year follow-up in 1991". <it>Eur J Clin Nutr</it>&#32;<b>48</b>&#32;(2): 85–91. PMID 8194497.</cite>&nbsp;</entry>
<entry id="24">
Perez-Llamas, F., et.al., <it>J Hum Nutr Diet</it>, Dec 1996, 9:6:463-471</entry>
<entry id="27">
 <cite style="font-style:normal">Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC&#32;(April 2006).&#32;"Trans fatty acids and cardiovascular disease". <it>N. Engl. J. Med.</it>&#32;<b>354</b>&#32;(15): 1601–13. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1056%2FNEJMra054035">
10.1056/NEJMra054035</weblink>. PMID 16611951.</cite>&nbsp;</entry>
<entry id="26">
 <cite style="font-style:normal">Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, Willett WC, Hu FB.&#32;(2005).&#32;"Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction". <it>J Nutr</it>&#32;<b>135</b>&#32;(3): 562–6. PMID 15735094.</cite>&nbsp;</entry>
<entry id="29">
 <cite style="font-style:normal">Berger J, Roncaglioni M, Avanzini F, Pangrazzi I, Tognoni G, Brown D&#32;(2006).&#32;"<weblink xlink:type="simple" xlink:href="http://jama.ama-assn.org/cgi/content/full/294/1/47">
Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials</weblink>". <it>JAMA</it>&#32;<b>295</b>&#32;(3): 306–13. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1001%2Fjama.295.3.306">
10.1001/jama.295.3.306</weblink>. PMID 16418466.</cite>&nbsp;</entry>
<entry id="28">
 <cite style="font-style:normal">Campbell CL, Smyth S, Montalescot G, Steinhubl SR&#32;(2007).&#32;"Aspirin dose for the prevention of cardiovascular disease: a systematic review". <it>JAMA</it>&#32;<b>297</b>&#32;(18): 2018–24. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1001%2Fjama.297.18.2018">
10.1001/jama.297.18.2018</weblink>. PMID 17488967.</cite>&nbsp;</entry>
<entry id="31">
<weblink xlink:type="simple" xlink:href="http://www.med-decisions.com/">
Welcome to Med-decisions!</weblink></entry>
<entry id="30">
 <cite style="font-style:normal">&#32;"<weblink xlink:type="simple" xlink:href="http://www.annals.org/cgi/content/full/136/2/157">
Aspirin for the primary prevention of cardiovascular events: recommendation and rationale</weblink>"&#32;&#32;(2002). <it>Ann Intern Med</it>&#32;<b>136</b>&#32;(2): 157–60. PMID 11790071.</cite>&nbsp;</entry>
<entry id="34">
 <cite style="font-style:normal">Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, Worthington HV, Durrington PN, Higgins JP, Capps NE, Riemersma RA, Ebrahim SB, Davey Smith G&#32;(2006).&#32;"Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review". <it>BMJ</it>&#32;<b>332</b>&#32;(7544): 752–60. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1136%2Fbmj.38755.366331.2F">
10.1136/bmj.38755.366331.2F</weblink>. PMID 16565093.</cite>&nbsp;</entry>
<entry id="35">
 <cite style="font-style:normal">Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J&#32;(2006).&#32;"n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review". <it>Am. J. Clin. Nutr.</it>&#32;<b>84</b>&#32;(1): 5–17. PMID 16825676.</cite>&nbsp; http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat1a.chapter.38290</entry>
<entry id="32">
 <cite style="font-style:normal">Ridker P, Cook N, Lee I, Gordon D, Gaziano J, Manson J, Hennekens C, Buring J&#32;(2005).&#32;"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women". <it>N Engl J Med</it>&#32;<b>352</b>&#32;(13): 1293–304. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1056%2FNEJMoa050613">
10.1056/NEJMoa050613</weblink>. PMID 15753114.</cite>&nbsp;</entry>
<entry id="33">
<weblink xlink:type="simple" xlink:href="http://circ.ahajournals.org/cgi/content/abstract/CIRCULATIONAHA.107.181546v1">
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update - Mosca et al., 10.1161/CIRCULATIONAHA.107.181546 - Circulation</weblink></entry>
<entry id="38">
 <cite style="font-style:normal">Keller T, Squizzato A, Middeldorp S&#32;(2007).&#32;"Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease". <it>Cochrane database of systematic reviews (Online)</it>&#32;(3): CD005158. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1002%2F14651858.CD005158.pub2">
10.1002/14651858.CD005158.pub2</weblink>. PMID 17636787.</cite>&nbsp;</entry>
<entry id="39">
Kasper, D.L., Braunwald, E., Fauci, A.S., Hauser, S.L., Longo, D.L., Jameson, J.L. (Eds.): Harrison's principles of internal medicine. 16th edition, McGraw-Hill, New York, 2005</entry>
<entry id="36">
 <cite style="font-style:normal">Yokoyama M, Origasa H, Matsuzaki M, et al&#32;(2007).&#32;"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis". <it>Lancet</it>&#32;<b>369</b>&#32;(9567): 1090–8. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1016%2FS0140-6736%2807%2960527-3">
10.1016/S0140-6736(07)60527-3</weblink>. PMID 17398308.</cite>&nbsp;</entry>
<entry id="37">
 <cite id="Reference-Awtry-2004" style="font-style:normal" class="book">Awtry, Eric H.;&#32;Joseph Loscalzo&#32;(2004).&#32;"Coronary Heart Disease", Cecil Essentials of Medicine, 6,&#32;Philadelphia, PA:&#32;Saunders,&#32;87-108. ISBN 978-0-7216-0147-2.</cite>&nbsp;</entry>
<entry id="42">
 <cite style="font-style:normal">Andraws R, Berger JS, Brown DL.&#32;(2005).&#32;"Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials". <it>JAMA</it>&#32;<b>293</b>&#32;(21): 2641–7. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1001%2Fjama.293.21.2641">
10.1001/jama.293.21.2641</weblink>. PMID 15928286.</cite>&nbsp;</entry>
<entry id="43">
 <cite style="font-style:normal">Simons M, Bonow RO, Chronos NA, et al&#32;(September 2000).&#32;"<weblink xlink:type="simple" xlink:href="http://circ.ahajournals.org/cgi/pmidlookup?view=long&amp;pmid=10982554">
Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary</weblink>". <it>Circulation</it>&#32;<b>102</b>&#32;(11): E73–86. PMID 10982554.</cite>&nbsp;</entry>
<entry id="40">
 <cite style="font-style:normal">Farrall M, Green FR, Peden JF, Olsson PG, Clarke R, Hellenius ML, Rust S, Lagercrantz J, Franzosi MG, Schulte H, Carey A, Olsson G, Assmann G, Tognoni G, Collins R, Hamsten A, Watkins H, on behalf of the PROCARDIS Consortium&#32;(2006).&#32;"<weblink xlink:type="simple" xlink:href="http://genetics.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371%2Fjournal.pgen.0020072">
Genome-Wide Mapping of Susceptibility to Coronary Artery Disease Identifies a Novel Replicated Locus on Chromosome 17</weblink>". <it>PLoS Genetics</it>&#32;<b>2</b>&#32;(5): e72. <document wordnetid="106470073" confidence="0.8">
<written_communication wordnetid="106349220" confidence="0.8">
<writing wordnetid="106362953" confidence="0.8">
<link xlink:type="simple" xlink:href="../994/422994.xml">
doi</link></writing>
</written_communication>
</document>
:<weblink xlink:type="simple" xlink:href="http://dx.doi.org/10.1371%2Fjournal.pgen.0020072">
10.1371/journal.pgen.0020072</weblink>. PMID 16710446.</cite>&nbsp;</entry>
<entry id="41">
 <cite style="font-style:normal">Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, Manttari M, Frick MH, Huttunen JK.&#32;(1992).&#32;"Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study". <it>Ann Intern Med</it>&#32;<b>116</b>&#32;(4): 273–8. PMID 1733381.</cite>&nbsp;</entry>
<entry id="44">
Stegmann, T.J.: A human growth factor in the induction of neoangiogenesis. Exp.Opin.Invest.Drugs 7: 2011-2015, 1998</entry>
<entry id="45">
Wagoner, L.E., Merrill, W., Jacobs, J., Conway, G., Boehmer, J., Thomas, K.,
Stegmann, T.J.: Angiogenesis Protein Therapy With Human Fibroblast Growth Factor (FGF-1): Results Of A Phase I Open Label, Dose Escalation Study In Subjects With CAD Not Eligible For PCI Or CABG. Circulation 116: 443, 2007
</entry>
</reflist>
</p>

</sec>
<sec>
<st>
See also</st>
<p>

<list>
<entry level="1" type="bullet">

<link xlink:type="simple" xlink:href="../846/4354846.xml">
Diet and Heart Disease</link></entry>
<entry level="1" type="bullet">

<physical_entity wordnetid="100001930" confidence="0.8">
<causal_agent wordnetid="100007347" confidence="0.8">
<agent wordnetid="109190918" confidence="0.8">
<link xlink:type="simple" xlink:href="../859/5209859.xml">
ApoA-1 Milano</link></agent>
</causal_agent>
</physical_entity>
</entry>
<entry level="1" type="bullet">

<compound wordnetid="105870180" confidence="0.8">
<link xlink:type="simple" xlink:href="../097/681097.xml">
Endothelium-derived relaxing factor</link></compound>
</entry>
</list>
</p>

</sec>
<sec>
<st>
 External links </st>
<p>

<list>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.americanheart.org/presenter.jhtml?identifier=3003499">
Risk Assessment of having a heart attack or dying of coronary artery disease</weblink>, from the American Heart Association.</entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.invisionguide.com/heart">
The InVision Guide to a Healthy Heart</weblink> An interactive website on the development and function of the cardiovascular system and cardiovascular diseases and consequences.  The website also features treatment options and preventative measures for maintaining a healthy heart.</entry>
<entry level="1" type="bullet">

 <weblink xlink:type="simple" xlink:href="http://www.rkliedtke.de/Coronary_Artery_Disease_us.html">
A Mechanism of a Metabolic Induction of Coronary Artery Disease in Chronic Kidney Disease</weblink>, Rainer K. Liedtke, MD </entry>
</list>
</p>

<p>

<table style=";" class="navbox" cellspacing="0">
<row>
<col style="padding:2px;">
<table style="width:100%;background:transparent;color:inherit;;" class="nowraplinks collapsible autocollapse " cellspacing="0">
<row>
<header colspan="2" style=";background:Silver" class="navbox-title">
<link xlink:type="simple" xlink:href="../662/512662.xml">
Cardiovascular disease</link>: <link xlink:type="simple" xlink:href="../276/69276.xml">
heart disease</link> - <link xlink:type="simple" xlink:href="../330/57330.xml">
Circulatory system</link> <link xlink:type="simple" xlink:href="../791/48791.xml">
pathology</link> (, )</header>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:MistyRose;;" class="navbox-group">
<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../853/65853.xml">
Ischaemic</link></disease>
/
<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../187/2138187.xml">
Acute coronary</link></disease>
</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../735/5069735.xml">
CHD</link></disease>
: <link xlink:type="simple" xlink:href="../876/5876.xml">
CAD</link> - <link xlink:type="simple" xlink:href="../061/744061.xml">
Coronary thrombosis</link> - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../145/5995145.xml">
Coronary vasospasm</link></disease>
 - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../779/17606779.xml">
Coronary artery aneurysm</link></disease>
<p>

<link xlink:type="simple" xlink:href="../862/65862.xml">
Angina pectoris</link> (<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../678/3213678.xml">
Prinzmetal's angina</link></disease>
) - <link xlink:type="simple" xlink:href="../969/60969.xml">
Myocardial infarction (heart attack)</link></p>
<p>

<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../795/8167795.xml">
Myocardial rupture</link></disease>
 - <link xlink:type="simple" xlink:href="../436/953436.xml">
Dressler's syndrome</link></p>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:MistyRose;;" class="navbox-group">
Layers</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<table style="width:100%;;;;" class="nowraplinks  navbox-subgroup" cellspacing="0">
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: MistyRose;" class="navbox-group">
<link xlink:type="simple" xlink:href="../944/244944.xml">
Pericardium</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../786/684786.xml">
Pericarditis</link> (<link xlink:type="simple" xlink:href="../741/4573741.xml">
Acute</link>, <link xlink:type="simple" xlink:href="../130/607130.xml">
Constrictive</link>) - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../656/3206656.xml">
Pericardial effusion</link></disease>
 - <link xlink:type="simple" xlink:href="../573/262573.xml">
Cardiac tamponade</link> - <link xlink:type="simple" xlink:href="../692/18844692.xml">
Hemopericardium</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: MistyRose;" class="navbox-group">
<link xlink:type="simple" xlink:href="../364/502364.xml">
Myocardium</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<link xlink:type="simple" xlink:href="../461/452461.xml">
Myocarditis</link><p>

<link xlink:type="simple" xlink:href="../133/46133.xml">
Cardiomyopathy</link>: <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../011/606011.xml">
Dilated</link></disease>
 (<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../398/12503398.xml">
Alcoholic</link></disease>
) - <link xlink:type="simple" xlink:href="../009/606009.xml">
Hypertrophic</link> - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../848/3224848.xml">
Restrictive</link></disease>
 (<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../302/5061302.xml">
Loeffler endocarditis</link></disease>
, <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../452/8090452.xml">
Cardiac amyloidosis</link></disease>
)</p>
<p>

<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../091/604091.xml">
Arrhythmogenic right ventricular dysplasia</link></disease>
</p>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: MistyRose;" class="navbox-group">
<link xlink:type="simple" xlink:href="../057/604057.xml">
Endocardium</link>/<link xlink:type="simple" xlink:href="../889/2532889.xml">
valve</link>s</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../659/9659.xml">
Endocarditis</link> (<link xlink:type="simple" xlink:href="../332/3071332.xml">
Subacute bacterial endocarditis</link>, <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../256/1010256.xml">
Libman-Sacks endocarditis</link></disease>
, <link xlink:type="simple" xlink:href="../949/1264949.xml">
Nonbacterial thrombotic endocarditis</link>)<it><link xlink:type="simple" xlink:href="../415/237415.xml">
mitral</link></it> (<link xlink:type="simple" xlink:href="../496/869496.xml">
regurgitation</link>, <link xlink:type="simple" xlink:href="../911/545911.xml">
prolapse</link>, <link xlink:type="simple" xlink:href="../092/646092.xml">
stenosis</link>) - <it><link xlink:type="simple" xlink:href="../414/237414.xml">
aortic</link></it> (<link xlink:type="simple" xlink:href="../278/194278.xml">
stenosis</link>, <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../743/651743.xml">
insufficiency</link></disease>
) - <it><link xlink:type="simple" xlink:href="../416/237416.xml">
tricuspid</link></it> (<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../159/7017159.xml">
stenosis</link></disease>
, <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../695/7904695.xml">
insufficiency</link></disease>
) - <it><link xlink:type="simple" xlink:href="../367/612367.xml">
pulmonary</link></it> (<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../377/3233377.xml">
stenosis</link></disease>
, <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../406/13716406.xml">
insufficiency</link></disease>
)</col>
</row>
</table>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:MistyRose;;" class="navbox-group">
<link xlink:type="simple" xlink:href="../897/650897.xml">
Conduction</link>/
<link xlink:type="simple" xlink:href="../562/5562.xml">
arrhythmia</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<table style="width:100%;;;;" class="nowraplinks  navbox-subgroup" cellspacing="0">
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: MistyRose;" class="navbox-group">
<link xlink:type="simple" xlink:href="../768/672768.xml">
Heart block</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../933/2282933.xml">
AV</link> (<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../829/665829.xml">
1°</link></disease>
, <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../555/673555.xml">
2°</link></disease>
, <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../763/637763.xml">
3°</link></disease>
) - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../061/1730061.xml">
Bundle branch</link></disease>
 (<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../531/3538531.xml">
Left</link></disease>
,  <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../553/1828553.xml">
Right</link></disease>
) - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../107/10728107.xml">
Bifascicular</link></disease>
/<link xlink:type="simple" xlink:href="../831/666831.xml">
Trifascicular</link> - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../940/12996940.xml">
Sinoatrial</link></disease>
 - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../141/414141.xml">
Sick sinus syndrome</link></disease>
 - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../931/5553931.xml">
Adams-Stokes syndrome</link></disease>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: MistyRose;" class="navbox-group">
<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../812/12929812.xml">
Pre-excitation syndrome</link></disease>
</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<link xlink:type="simple" xlink:href="../999/384999.xml">
Wolff-Parkinson-White</link> - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../176/3733176.xml">
Lown-Ganong-Levine</link></disease>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: MistyRose;" class="navbox-group">
<link xlink:type="simple" xlink:href="../581/160581.xml">
Tachycardia</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../943/2994943.xml">
Paroxysmal</link></disease>
 - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../702/877702.xml">
Supraventricular</link></disease>
 (<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../563/938563.xml">
AV nodal reentrant</link></disease>
, <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../551/9853551.xml">
Accelerated idioventricular rhythm</link></disease>
, <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../476/2166476.xml">
Sinus</link></disease>
) - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../376/714376.xml">
Ventricular</link></disease>
 (<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../936/685936.xml">
Torsades de pointes</link></disease>
, <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../869/7673869.xml">
Catecholaminergic polymorphic</link></disease>
)</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: MistyRose;" class="navbox-group">
Premature contraction</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../900/2857900.xml">
Atrial</link></disease>
 - <link xlink:type="simple" xlink:href="../476/230476.xml">
Ventricular</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: MistyRose;" class="navbox-group">
Flutter/<link xlink:type="simple" xlink:href="../024/419024.xml">
fibrillation</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../034/623034.xml">
Atrial flutter</link> - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../742/17660742.xml">
Ventricular flutter</link></disease>
 - <link xlink:type="simple" xlink:href="../138/328138.xml">
Atrial fibrillation</link> (<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../514/8981514.xml">
Familial</link></disease>
) - <link xlink:type="simple" xlink:href="../858/183858.xml">
Ventricular fibrillation</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: MistyRose;" class="navbox-group">
<link xlink:type="simple" xlink:href="../732/80732.xml">
Pacemaker</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../251/9259251.xml">
Wandering pacemaker</link></disease>
 - <link xlink:type="simple" xlink:href="../751/14251751.xml">
Ectopic pacemaker</link> - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../560/4897560.xml">
Parasystole</link></disease>
 -  <link xlink:type="simple" xlink:href="../294/8306294.xml">
Multifocal atrial tachycardia</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: MistyRose;" class="navbox-group">
<link xlink:type="simple" xlink:href="../747/363747.xml">
Long QT syndrome</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../064/1557064.xml">
Romano-Ward syndrome</link></disease>
 - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../120/1557120.xml">
Andersen-Tawil syndrome</link></disease>
 - <link xlink:type="simple" xlink:href="../079/1516079.xml">
Jervell and Lange-Nielsen syndrome</link></col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";padding-left:0em;padding-right:0em;background-color: MistyRose;" class="navbox-group">
<link xlink:type="simple" xlink:href="../575/60575.xml">
Cardiac arrest</link></col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../267/5696267.xml">
Sudden cardiac death</link></disease>
 - <link xlink:type="simple" xlink:href="../465/220465.xml">
Asystole</link> - <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../433/1364433.xml">
Pulseless electrical activity</link></disease>
</col>
</row>
</table>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col style=";background:MistyRose;;" class="navbox-group">
Other</col>
<col style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<link xlink:type="simple" xlink:href="../051/3219051.xml">
Cardiomegaly</link> - <link xlink:type="simple" xlink:href="../577/2311577.xml">
Ventricular hypertrophy</link> (<link xlink:type="simple" xlink:href="../395/1179395.xml">
Left</link>, <disease wordnetid="114070360" confidence="0.9508927676800064">
<link xlink:type="simple" xlink:href="../237/5595237.xml">
Right</link></disease>
/<link xlink:type="simple" xlink:href="../300/368300.xml">
Cor pulmonale</link>)<p>

<link xlink:type="simple" xlink:href="../930/249930.xml">
Heart failure</link> (<link xlink:type="simple" xlink:href="../744/2950744.xml">
Cardiac asthma</link>) - <link xlink:type="simple" xlink:href="../735/412735.xml">
Rheumatic fever</link></p>
</col>
</row>
<row style="height:2px">

</row>
<row>
<col colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-even">
<it>See also , ''</it></col>
</row>
</table>
</col>
</row>
</table>
</p>




</sec>
</bdy>
</entity>
</article>
